Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02078609 |
Title | A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | NLD | ITA | FRA | DEU | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Ann Arbor | Michigan | 48109 | United States | Details | |
Novartis Investigative Site | Prahran | Victoria | 3181 | Australia | Details | |
Novartis Investigative Site | Marseille | 13273 | France | Details | ||
Novartis Investigative Site | Ulm | 89081 | Germany | Details | ||
Novartis Investigative Site | Milano | MI | 20132 | Italy | Details | |
Novartis Investigative Site | Milano | MI | 20162 | Italy | Details | |
Novartis Investigative Site | Roma | RM | 00133 | Italy | Details | |
Novartis Investigative Site | Shinagawa ku | Tokyo | 141 8625 | Japan | Details | |
Novartis Investigative Site | Amsterdam | 1081 HV | Netherlands | Details |